trial

Biological Evaluation of Dietary Supplement Liposomal Glutathione

NCTId NCT01967667
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 11 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2021-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
11 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2014-04
Primary completion
2021-02
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Liposomal glutathione

Sponsors

University of Maryland, Baltimore CountyLead Sponsor

Investigators

1
L. Elliot Hong, MDPrincipal Investigator

Sites

1 total
Catonsville, United States

Facts & assertions

4 sourced
Enrollment
11
Phase
NA
Primary Completion Date
2021-02
Status
COMPLETED
relationships
The graph out of here
drug
Liposomal glutathione
drug
lead_sponsor
University of Maryland, Baltimore County
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
L. Elliot Hong, MD
person